We are live on ! Find out more
DF

DC Funds Portfolio holdings

AUM $1.49M
1-Year Est. Return 18.57%
This Fund
S&P 500
This Quarter Est. Return
+4.55%
1 Year Est. Return
-18.57%
3 Year Est. Return
-38.34%
5 Year Est. Return
-87.14%
10 Year Est. Return
–
AUM
$2.15M
AUM Growth
+$86.1K
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TCRX icon
1
TScan Therapeutics
TCRX
$48.6M
$914K 42.43%
630,000
– –
HOWL icon
2
Werewolf Therapeutics
HOWL
$17.2M
$642K 29.83%
589,102
– –
BRNS
3
Barinthus Biotherapeutics
BRNS
$22.8M
$597K 27.74%
642,204
– –

Similar funds

HGCK
HPC Germany & Co KG Potsdam, Germany $1.48M AUM 24.97% 1-Year Est. Return
DILIH
Dai-ichi Life International Holdings Tokyo, Japan $1.52M AUM
SH
Svenska Handelsbanken Stockholm, Sweden $1.38M AUM 61.04% 1-Year Est. Return
CAM
Creekmur Asset Management Morton, Illinois $1.33M AUM
SCM
SVB Capital Management Menlo Park, California $2.07M AUM 23.37% 1-Year Est. Return
AMC
Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return
HB
Huntington Bancshares Columbus, Ohio $777K AUM
SI
Sapience Investments Newport Beach, California $772K AUM 24.07% 1-Year Est. Return

DC Funds's Q2 2025 Portfolio in Review

As of Q2 2025, DC Funds held 3 positions worth $2.15M, up 4.2% from $2.07M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2025: portfolio turnover was 0%. DC Funds opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • DC Funds's ten largest holdings make up 100% of its $2.15M portfolio in Q2 2025.
  • DC Funds opened 0 new positions and closed 0 in Q2 2025.
  • DC Funds's portfolio value rose 4.2% quarter-over-quarter to $2.15M.

Based on DC Funds's 13F filing for Q2 2025, filed 14 Aug 2025.